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Abstract
Background: Bilateral posterior periventricular nodular heterotopia PNH is a complex malformation of cortical
development with imaging features distinguishing it from classic bilateral PNH associated with filamin (FLNA)
mutations. It distinctively consists of variably sized nodules of neurons along the trigones and temporal or occipital
horns of the lateral ventricles and spectrum of developmental disorders of the mid-/hindbrain. This association
suggests that pPNH is part of a more diffuse process of posterior or infrasylvian brain developmental abnormalities
other than just a disorder of neuronal migration.
Case presentation: This report describes the first case of an Italian young girl featuring pPNH and severe
hyperphagic obesity. At the time of our first examination at age 3 years of age she was severely obese (body mass
index, BMI 45.9 Kg/m2) and food-seeking behavior in the free-living situation was reported by the relatives. She
showed normal linear growth and cognition, but mildly dysmorphic facial traits including deeply-set eyes,
prominent zygomatic bones, downturned mouth corners and low-set ears. Over the years, the patient progressively
developed further massive weight gain (at age 9 years, her BMI was 60.4 Kg/m2) and hyperphagia was confirmed
by an ad libitum test meal. During follow-up, she presented limitations in walking capacity and in physical
functioning due to the disabling obesity. On the basis of distinctive neuro-radiological findings pPNH was
diagnosed, in absence of history of seizures.
Conclusion: The present case may contribute to the expansion of the phenotypic expressions of this distinctive
complex malformation.
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Background
Periventricular nodular heterotopias (PNHs) are com-
mon malformations of cortical development consisting
of variably sized nodules of neurons along the lateral
ventricles, associated with many clinical syndromes and
different neuroimaging phenotypes.
Although traditionally PNHs have been considered the
result of abnormal neuronal migration [1, 2] recent evi-
dence has suggested that the primary cause may be a dis-
ruption of neuroependyma, which impairs postmitotic
neurons from attaching to radial glial cells and, therefore,
undermines initiation of the migration process [3, 4].
Patients with PNH represent a heterogeneous group
from both genetic and phenotypic points of view. The
classical bilateral X-linked form is usually caused by mu-
tations of the Filamin A (FLNA) gene [5] and is charac-
terized by bilateral symmetric heterotopic nodules along
the frontal horns and bodies of the lateral ventricles.
The clinical spectrum of FLNA mutations is wide and
missense mutations or mosaicism may result in unilat-
eral forms or nonlethal expression in males [6]. A rare
autosomal recessive form is caused by mutations in the
ADP-ribosylation factor guanine nucleotide-exchange
factor-2 (ARFGEF2) gene featuring microcephaly and
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delayed myelination in addition to bilateral PNH [7].
However, associations with several single-gene disorders,
chromosomal anomalies [8] and disruptive causes [9, 10]
have been reported, suggesting that heterogeneous gen-
etic and nongenetic processes may cause PNH.
PNH can occur in different patterns and can be associ-
ated with different types of malformations. Indeed, they
may either be found incidentally in asymptomatic pa-
tients, or more frequently discovered after imaging is
performed for delayed development or epilepsy [11–13].
Fifteen subtypes have been so far identified on the basis
of heterotopic nodules distribution and coexisting birth
defects [14]. Bilateral posterior PNH (pPNH), the second
most common variant after classic fronto-central PNH,
refers to heterotopia exclusively located in the trigones
and temporal or occipital horns of the lateral ventricles
[15] and distinctively shows associations with a spectrum
of infrasylvian developmental abnormalities.
Case presentation
We describe the case of an Italian girl with severe early-
onset obesity. She was second child of healthy, non-
consanguineous parents. Gestation was uneventful but
prenatal central nervous system ultrasound showed slight
dilatation of the right lateral ventricle. Thus, the child was
delivered at 38 weeks of pregnancy by Caesarian section
and her birth weight and length were 3.17 kg (25–50th
centile) and 48 cm (25–50th centile), respectively.
She presented neonatal hypotonia, delayed psycho-
motor development (she was able to sit without support
at 18 months and started walking at 3,5 years) and rapid
weight gain (her reported weight at 6 months was 15
Kg) with normal linear growth.
At the time of our first examination she was 3 years
old and severely obese: her body mass index (BMI)
height and weight were 45.9 Kg/m2 (SDS-BMI: out of
age range), 122 cm (SDS-height: 6.77) and 68 Kg (SDS-
weight: 34.6), respectively (Fig. 1a). She was reported to
be hyperphagic, showing food-seeking behavior in the
free-living situation. There was no phenotype of morbid
obesity in the parents or relatives.
Dysmorphic facial traits including deeply-set eyes,
prominent zygomatic bones, downturned mouth corners
and mildly low-set ears were also present (Fig. 1a-b). A
comprehensive developmental assessment showed nor-
mal cognition, communication and motor skills. Oph-
thalmologic exam documented a mild left convergent
strabismus but neither retinopathy, nor eye movement
disturbances. Her blood pressure was in the normal
range as well as electrocardiographic and echocardio-
graphic evaluations. Radiologic assessment of the skel-
eton and hands showed no anatomical abnormalities.
Fig. 1 Patient’s clinical features. Patient at 3 (a) and 9 (b) years. Note the facial features, including prominent zygomatic bones and downturned
mouth corners
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The laboratory tests revealed hyperinsulinemia (36
μU/ml) and increased levels of liver enzymes (alanine
aminotransferase -ALT- 41 UI/L; aspartate aminotrans-
ferase -AST- 73 UI/L; alkaline phosphatase -ALP- 334
UI/L; gamma glutamil transferase -γGT- 82 UI/L). Endo-
crinological assessment disclosed only a mild increase in
adreno-corticotropic hormon (ACTH: 92 pg/ml) with
normal serum cortisol levels (13 μg/dl) in line with the
degree of obesity. Clinical signs of insulin resistance
(acanthosis nigricans of the neck and armpits) and hep-
atomegaly (also confirmed by abdominal ultrasound
scan) were also detected.
She had premature pubertal development and menar-
che at seven years of age, with post-puberal gonadotro-
pins and sexual hormones levels.
She progressively developed further massive weight gain
and, at the time she was nine years old, her BMI, height
and weight were 60.4 Kg/m2 (SDS-BMI: 13.6), 145 cm
(SDS-height: 2) and 127 Kg (SDS-weight: 23.2) respect-
ively (Fig. 1b). Hyperphagia was confirmed by an 8.2 MJ
energy intake in an 18 MJ ad libitum test meal. The de-
gree of hyperphagia (120.6 KJ/Kg lean mass) was compar-
able to that reported in 50 six-year old patients with
heterozygous mutations in the melanocortin 4 receptor
gene [16] and in one patient with congenital deficiency of
prohormone convertase 1/3 [17]. Basal metabolic rate
measured by indirect calorimetry after an overnight fast
was comparable (8.2 MJ/d) to that predicted by age and
gender-specific equations (8 MJ/d) [18].
During an abdominal ultrasound reevaluation, a 25 cm
simple ovarian cyst was also detected.
She presented severe impairment of walking capacity
and worsening limitations in physical functioning due to
her disabling massive obesity. In her primary education,
mild intellectual disability appeared as she was perceived
by her teacher as having special educational needs, so
that she started receiving an inclusive classroom
program.
Brain Magnetic Resonance Imaging (MRI) showed
complex developmental abnormalities consisting of bi-
lateral symmetric nodules of grey matter lining the walls
of the trigones and occipital horns of lateral ventricles
colpocephaly, transmantle bands extending from the
posterior nodules to the overlying dysplastic cortex, hip-
pocampal malrotation, cerebellar hemispheres asym-
metry, vermis hypoplasia with large cisterna magna and
missing of the normal T1 hyperintensity of neurohyp-
ophysis (“bright spot”) (Fig. 2). On the basis of these
neuro-radiological findings pPNH was diagnosed.
An EEG, performed for the concern of seizures,
showed normal findings with mild and diffuse non-
specific anomalies.
Genetic testing was performed. The high resolution
karyotype analysis and the array comparative genomic
hybridisation (CGH) were negative. Neither deletions
and duplications of the whole locus, nor point mutations
in the coding exons of FLNA gene were detected. Add-
itionally, DNA methylation analysis within the chromo-
some 15q11.2-q13 excluded the Prader-Willi syndrome.
Conclusion
The first case featuring pPNH and severe hyperphagia/
obesity is herein reported.
Patients with pPNH are characterized by nodules typ-
ically located along the atria and temporal horns of the
lateral ventricles and developmental disorders of the
mid-/hindbrain. This association suggests that pPNH is
part of a more diffuse process of posterior or infrasylvian
brain maldevelopment other than just a disorder of
neuronal migration [15].
Cerebellar signs ranging from severe cerebellar syn-
drome to mild dysmetria, nystagmus and dysarthria were
reported in patients affected by pPNH. Focal epilepsy
and normal to mildly impaired cognitive level were also
documented [14, 19]. The severe ambulation impairment
observed in our patient was not ascribed to cerebellar
abnormalities but to the disabling obesity. Besides, our
patient did not present either mental retardation or his-
tory of seizures.
In keeping with the marked reduction in white matter
volume observed in pPNH, some authors hypothesized
that this pattern presents greater frequency of connectiv-
ity abnormalities [20]. Given also that in Prader-Willi
syndrome altered functional connectivity alterations
among the brain regions implicated in eating and re-
warding have been reported [21], it would be intriguing
to speculate that in pPNH some theoretical neural path-
ways that control feeding behavior might be disrupted.
However, we failed to observe other signs of hypothal-
amic dysfunction such as temperature instability, high
pain threshold, sleep disordered breathing and endocrine
abnormalities. Neuro-radiologic alterations of hypothal-
amus anatomy were excluded as well.
Previous observations have demonstrated that PNH is
clinically and genetically heterogeneous and causative
genes appear to be scattered through the genome.
Whereas the classical bilateral X-linked form is usually
caused by mutations of the FLNA gene involved in regu-
lation of cell stability, filopodial protrusion and motility
across various biological systems, in contrast, the genet-
ics of pPNH is so far unknown. In fact, the posterior
pattern of PNH does not harbour mutations in FLNA.
Accordingly, in our patient no FLNA mutations were de-
tected. Thus, pPNH may be considered as a specific
malformation complex, which entails a more extensive
disturbance in cortical development and putatively re-
flects aberrations in different mechanisms or pathways
to classic PNH. The association of pPNH with
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mid-/hindbrain malformations may suggest that genes
expressed more strongly in the posterior telencephalon
might be likely causative candidates [20] in this pattern
of PNH.
The hyperphagic behavior and massive obesity observed
in our patient represent a novel clinical feature in pPNH.
Although the nosologic classification of pPNH is inher-
ently limited by the lack of genotype-phenotype correla-
tions, and a concomitant monogenic cause (e.g.
melanocortin 3 or 4 receptor, leptin and leptin receptor
mutations) of the hyperphagic behavior cannot be ruled
out, our report reinforces the clinical, and putatively gen-
etic, heterogeneity of pPNH. After all, some of these mu-
tations appear not very likely on the basis of the clinical
findings. Namely, disorders in leptin production or action
result, beyond severe early-onset obesity, in altered im-
mune function due to T-cell defects and pubertal delay
[22], the latter being in conflict with the premature puber-
tal development and menarche of our patient. Similarly,
children with mutations in the neuroendocrine-specific
enzyme prohormone convertase 1/3 present early-onset
obesity, reactive hypoglycemia, enteropathy, impaired
proopiomelanocortin processing (with consequent de-
crease in ACTH plasma concentrations) and neuroendo-
crine dysfunction [23], features that were not present in
our patient. Rather, we found a mild increase in ACTH
levels (considered in line with the degree of obesity).
In conclusion, we believe that the present case may
contribute to the expansion of the phenotypic expressions
of this distinctive complex malformation. However, this
case could also represent a new disease entity.
Consent
Written informed consent was obtained from the minor
child’s mother for publication of this Case report and
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form to the routine standard care.
Fig. 2 Brain Magnetic Resonance findings. Axial T1 weigthed image (a) and sagittal T2 weighted image (b) show PNH lining the wall of trigones
and occipital horns of lateral ventricles (arrows ↗) and asymmetric colpocephaly. Sagittal T2 weighted image demonstrates small cerebellar vermis
(arrows ↗) and megacisterna magna (asterisk *) (c). Coronal T1 image shows hypoplasia of right cerebellar hemisphere (arrows ↗) (d)
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